✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Mangalam Drugs And Organics Ltd.

MANGALAM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹40 Cr.
P/E
0.00

Mangalam Drugs And Organics Ltd.

  • Mangalam Drugs&Org.
  • Lasa Supergenerics
  • Tyche Inds

FAQs on Mangalam Drugs And Organics Ltd. Shareprice

Mangalam Drugs&Org. has given lower returns compared to its competitors.
Mangalam Drugs&Org. has grown at ~-21.73% over the last 8yrs while peers have grown at a median rate of -1.26%

Mangalam Drugs&Org. is not expensive.
Latest PE of Mangalam Drugs&Org. is 0.0, while 3 year average PE is 16.02.
Also latest EV/EBITDA of Mangalam Drugs&Org. is 10.74 while 3yr average is 12.03.

View FAQ's On Business

Growth Table

  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Balance Sheet

  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Cash Flow

  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Quarterly Results

  • Mangalam Drugs And Organics Ltd.
  • Lasa Supergenerics
  • Tyche Inds

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Mangalam Drugs And Organics Ltd. Financials

Mangalam Drugs&Org. balance sheet is weak and might have solvency issues

Yes, The net debt of Mangalam Drugs&Org. is increasing.
Latest net debt of Mangalam Drugs&Org. is ₹85.7 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹83.1 Crs.

The profit is oscillating.
The profit of Mangalam Drugs&Org. is -₹19.8 Crs for TTM, ₹6.72 Crs for Mar 2025 and -₹9.07 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mangalam Drugs&Org. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech